![]() BioSenic BioSenic (formerly known as Bone Therapeutics) is a biotechnology company specializing in the treatment of osteo-articular diseases using cell therapy. | ![]() Immunovia Immunovia engages in the development of a technology platform based on antibody microarray analysis. | Hememics Biotechnologies HeMemics Biotechnologies is a company that provides diagnostic testing solutions. | ![]() CHA Vaccine Institute CHA Vaccine Institute ((주)차백신연구소, formerly known as Dubeel) is a research-oriented biotechnology company. | |
Founding Date | Founding Date 2006 | Founding Date 2007 | Founding Date 2007 | Founding Date 2000 |
Type | Type Public | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Charleroi, BE HQ Charleroi, BE | Locations Lund, SE HQ Lund, SE Marlborough, US | Locations Gaithersburg, US HQ | Locations Seongnam, KR HQ |
Employees | Employees 20 | Employees 9 | Employees 10 | Employees 477% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr685k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₩370.7m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods kr136k (FY, 2025) | Cost of goods N/A | Cost of goods ₩23.9m (FY, 2024) |
Gross profit | Gross profit €3.1m (FY, 2024) | Gross profit kr549k (FY, 2025) | Gross profit N/A | Gross profit ₩355.1m (FY, 2024) |
Net income | Net income (€6.7m) (FY, 2024) | Net income (kr145.9m) (FY, 2025) | Net income N/A | Net income (₩10.1b) (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 10.4m | Total funding raised $ 5.2m | Total funding raised $ 2.5m | Total funding raised N/A |

Immunovia engages in the development of a technology platform based on antibody microarray analysis.
View companyHeMemics Biotechnologies is a company that provides diagnostic testing solutions.
View company
CHA Vaccine Institute ((주)차백신연구소, formerly known as Dubeel) is a research-oriented biotechnology company.
View company